Mesulergine is a psychoactive drug of the ergoline chemical class that acts on serotonin and dopamine receptors.

The compound had entered clinical trials for the treatment of Parkinson's disease, however further development was halted due to adverse histological abnormalities in rats.





This page contains text from Wikipedia, the Free Encyclopedia - http://en.wikipedia.org/wiki/Mesulergine

This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.